Overview
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| VentureLab | venturelab.swiss |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 5, 2021 | Alibion ceases operations | Biotech is a high-risk business. The chances that a pre-clinical stage project fails to make it to the market are higher than that of succeeding. However, there are only a few founders speaking about failure. One of them is Daniel Schmid Ro... |
| May 19, 2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | BIO International Convention has transformed into BIO Digital to bring together players in the biotech industry to exchange ideas even in times when it is impossible to gather physically. From 8 - 12 June, more than 2300 companies from all ... |
| May 19, 2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | |
| Oct 4, 2019 | A new cohort joins the BaseLaunch accelerator | |
| Apr 9, 2019 | Alibion kicks off pre-clinical studies to address Rheumatoid arthritis | |
| Oct 16, 2018 | Scailyte wins Start JLM competition |
Reviews 0
FAQ about Alibion
When was Alibion founded?
Alibion was founded in 2018.
Who has invested in Alibion?
Parsers VC lists 2 investors of Alibion, among them VentureLab.
What has the press written about Alibion?
Parsers VC has collected 7 articles mentioning Alibion, among them “Alibion ceases operations” (Jan 5, 2021) and “Eleven Swiss start-ups on the virtual BIO Digital stage” (May 19, 2020).
Is Alibion still active?
Yes, Alibion is active; its latest activity on Parsers VC dates from Jan 5, 2021.